Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Steuber

Showing results (131-140 of 209) with videos related to

Pageof 21
Sort By:
Urologic Oncology|August 4, 2024
Impact of time to metastatic disease onset and extent of disease volume across metastatic hormone-sensitive and castration-resistant prostate cancerMike Wenzel, Benedikt Hoeh, Philipp Kopf, et al.
Journal of the American Geriatrics Society|June 26, 2024
Treatment patterns and oncological outcomes of older adults with metastatic prostate cancer in real-world settingMike Wenzel, Benedikt Hoeh, Nele Wagner, et al.
BJU International|September 24, 2013
Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European populationAndreas Becker, Pierre Tennstedt, Jens Hansen, et al.
World Journal of Urology|July 14, 2023
Outcome of patients with epithelialized cavity formation after excessive vesicourethral anastomotic leak post radical prostatectomyDejan K Filipas, Markus Graefen, Margit Fisch, et al.
British Journal of Cancer|May 30, 2020
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomyAlexander Haese, Amy L Tin, Sigrid V Carlsson, et al.
Prostate Cancer and Prostatic Diseases|September 3, 2020
External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based studyLara Franziska Stolzenbach, Marina Deuker, Claudia Collà-Ruvolo, et al.
International Urology and Nephrology|December 14, 2011
The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomyJan Schmitges, Quoc-Dien Trinh, Marco Bianchi, et al.
JBMR Plus|December 16, 2024
Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancerMike Wenzel, Benedikt Hoeh, Clara Humke, et al.
European Urology|April 24, 2007
Marked gene transcript level alterations occur early during radical prostatectomyThorsten Schlomm, Esther Näkel, Andreas Lübke, et al.
European Urology Focus|July 30, 2017
Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control StudyThomas Steuber, Kasper D Berg, Martin A Røder, et al.
Pageof 21

Showing results (131-140 of 209) with videos related to

Sort By:
Pageof 21
Urologic Oncology|August 4, 2024
Impact of time to metastatic disease onset and extent of disease volume across metastatic hormone-sensitive and castration-resistant prostate cancerMike Wenzel, Benedikt Hoeh, Philipp Kopf, et al.
Journal of the American Geriatrics Society|June 26, 2024
Treatment patterns and oncological outcomes of older adults with metastatic prostate cancer in real-world settingMike Wenzel, Benedikt Hoeh, Nele Wagner, et al.
BJU International|September 24, 2013
Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European populationAndreas Becker, Pierre Tennstedt, Jens Hansen, et al.
World Journal of Urology|July 14, 2023
Outcome of patients with epithelialized cavity formation after excessive vesicourethral anastomotic leak post radical prostatectomyDejan K Filipas, Markus Graefen, Margit Fisch, et al.
British Journal of Cancer|May 30, 2020
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomyAlexander Haese, Amy L Tin, Sigrid V Carlsson, et al.
Prostate Cancer and Prostatic Diseases|September 3, 2020
External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based studyLara Franziska Stolzenbach, Marina Deuker, Claudia Collà-Ruvolo, et al.
International Urology and Nephrology|December 14, 2011
The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomyJan Schmitges, Quoc-Dien Trinh, Marco Bianchi, et al.
JBMR Plus|December 16, 2024
Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancerMike Wenzel, Benedikt Hoeh, Clara Humke, et al.
European Urology|April 24, 2007
Marked gene transcript level alterations occur early during radical prostatectomyThorsten Schlomm, Esther Näkel, Andreas Lübke, et al.
European Urology Focus|July 30, 2017
Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control StudyThomas Steuber, Kasper D Berg, Martin A Røder, et al.
Pageof 21